Identifying patients that will respond to a particular therapy remains a key challenge in precision oncology. Here, in gastric cancer, the authors show that circulating tumour DNA can predict recurrence, provided that the signal from white blood cells is filtered out.
- Alessandro Leal
- Nicole C. T. van Grieken
- Victor E. Velculescu
